Home > Boards > US Listed > Biotechs > Fluidigm Corp. (FLDM)

Detection of human and viral full-length RNA using

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Hole shot King Member Profile
Member Level 
Followed By 172
Posts 18,517
Boards Moderated 1
Alias Born 01/08/08
160x600 placeholder
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 11/24/2020 5:25:00 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 11/24/2020 5:24:57 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 11/24/2020 5:24:40 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 11/24/2020 5:24:21 PM
Key Regulatory Body in India Grants Commercial License for Fluidigm Saliva-Based Advanta Dx SARS-CoV-2 RT-PCR Assay GlobeNewswire Inc. - 11/24/2020 8:30:00 AM
Fluidigm to Participate at the Piper Sandler 32nd Annual Virtual Healthcare Conference GlobeNewswire Inc. - 11/20/2020 9:54:23 PM
Study Utilizing Imaging Mass Cytometry Details Changes in Lung Tissue Architecture at the Single-Cell Level in Patients with ... GlobeNewswire Inc. - 11/19/2020 8:30:00 AM
Fluidigm COVID-19 Community Connect Program Builds a Network of Testing Partners to Increase Access of Saliva-Based SARS-CoV-... GlobeNewswire Inc. - 11/17/2020 8:30:00 AM
Fluidigm to Present at Upcoming Health Care Investor Conference GlobeNewswire Inc. - 11/10/2020 8:30:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/5/2020 4:13:27 PM
Fluidigm Announces Third Quarter 2020 Financial Results GlobeNewswire Inc. - 11/5/2020 4:05:00 PM
Fluidigm and Healthvana Partner to Offer COVID-19 Test Results Delivery through Innovative Digital Platform GlobeNewswire Inc. - 11/5/2020 8:30:00 AM
Fluidigm Mass Cytometry Technologies, Including CyTOF, Imaging Mass Cytometry and Maxpar Direct, Utilized in More than 100 Na... GlobeNewswire Inc. - 11/3/2020 8:30:00 AM
Dante Labs Launching COVID-19 Testing in Europe Utilizing Fluidigm Pathogen Detection Kit on Biomark HD Platform GlobeNewswire Inc. - 11/2/2020 8:30:00 AM
Fluidigm to Offer Millions of Advanta COVID-19 Tests at Low Cost to U.S. Colleges and Universities GlobeNewswire Inc. - 10/8/2020 8:30:10 AM
Fluidigm Announces Conference Call and Webcast of Third Quarter 2020 Financial Results GlobeNewswire Inc. - 10/6/2020 4:02:10 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/29/2020 6:01:42 AM
Fluidigm Joins Global Consortium of Cancer Prevention Experts GlobeNewswire Inc. - 9/16/2020 8:45:10 AM
ImmunoGenomics and Vero Diagnostics Providing COVID-19 Testing with Saliva-Based Advanta Dx SARS-CoV-2 RT-PCR Assay on Biomar... GlobeNewswire Inc. - 9/16/2020 8:30:10 AM
Fluidigm Announces Agenda for 9th Annual Mass Cytometry Summit GlobeNewswire Inc. - 9/15/2020 8:30:10 AM
Fluidigm Achieves Initial Milestone under NIH Rapid Acceleration of Diagnostics Agreement GlobeNewswire Inc. - 9/8/2020 8:30:10 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/8/2020 6:10:43 AM
Fluidigm to Participate at the 2020 Cantor Virtual Global Healthcare Conference GlobeNewswire Inc. - 9/2/2020 4:02:10 PM
Fluidigm Granted FDA Emergency Use Authorization for Saliva-Based Advanta Dx SARS-CoV-2 RT-PCR  Assay for COVID-19 GlobeNewswire Inc. - 8/25/2020 11:00:10 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/24/2020 7:20:31 PM
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences